Quick Answer
Disc Medicine, Inc. reported Earnings Per Share Diluted of $6.01 (loss) per share for the year ending 2025.
- Disc Medicine, Inc. showed a decrease of -51.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Disc Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.38 (loss) per share | Q3 2021: $0.43 (loss) per share | Q1 2022: $10.67 (loss) per share | Q2 2022: $10.14 (loss) per share | Q3 2022: $16.82 (loss) per share | Q1 2023: $1.20 (loss) per share | Q2 2023: $0.74 (loss) per share | Q3 2023: $0.58 (loss) per share | Q1 2024: $1.09 (loss) per share | Q2 2024: $1.03 (loss) per share | Q3 2024: $0.89 (loss) per share | Q1 2025: $1.02 (loss) per share | Q2 2025: $1.58 (loss) per share | Q3 2025: $1.77 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Disc Medicine, Inc.'s Earnings Per Share Diluted has grown by 85.3%.
- Historical annual values: Fiscal year 2025: $6.01 (loss) per share | Fiscal year 2024: $3.96 (loss) per share | Fiscal year 2023: $3.42 (loss) per share | Fiscal year 2022: $45.05 (loss) per share | Fiscal year 2021: $40.95 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: